Objective 1: To test whether treatment with plasma exchange improves renal recovery in patients with light chain cast nephropathy Objective 2: To compare renal outcomes among patients treated with plasma exchange versus daratumumab-based regimens versus non-daratumumab based-regimens.
Multiple Myeloma, Light Chain Nephropathy, Acute Kidney Injury
Objective 1: To test whether treatment with plasma exchange improves renal recovery in patients with light chain cast nephropathy Objective 2: To compare renal outcomes among patients treated with plasma exchange versus daratumumab-based regimens versus non-daratumumab based-regimens.
Novel Treatments in Improving Renal Outcomes in Light Chain Cast Nephropathy
-
Brigham and Women's Hospital, Boston, Massachusetts, United States, 02130
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
Yes
Brigham and Women's Hospital,
Shruti Gupta, MD, PRINCIPAL_INVESTIGATOR, Brigham and Women's Hospital
2026-06-01